Join us at BIO International 2018 in Boston, MA

June 4 - 7, 2018 at the Boston Convention Center

At BIO International 2018, you can learn about BioReliance® development and manufacturing capabilities, SAFC® portfolio of customized and ready-to-use raw material solutions, and Millipore portfolio of biomanufacturing systems, assemblies, and filtration products. Merck is here for your bioprocessing needs, if you want to build your own capabilities, or if you look for partners.

Let’s explore your path to success.

Visit the Event Website

Biotech Executive Panel: Shifting the BioDevelopment Paradigm
Monday June 4th, from 4 - 5:15 pm. Room 206AB, Level 2, Boston Convention and Exhibition Center

Join the discussion with biotech executives on how they have navigated the development process from DNA to market and hear from investors on the latest trends in funding innovation. Featuring panelists:

• Konstantinos Efthymiopoulos,
  Chairman of Synnafix
  
  
• Jodie P. Morrison,
  Kerrys Pharmaceuticals Chief Executive Officer
  
  
• Magdalena Leszczyniecka,
  President and CEO of STC Biologics and Member of Advisory Network at Sectoral Asset Management
  
  
• Alicia Irurzun Lafitte,
  M Ventures Healthcare

Feature Presentation at Massachusetts Pavilion
Tuesday June 5th at 11:30 am, Massachusetts Pavilion #349

“Envisioning the World Without Barriers to Bioproduction”

Hear our pitch for a world without barriers to bioproduction. Andrew Bulpin, Head of Process Solutions, Merck, will talk about how make that vision possible. Our BioReliance® End-to-End Solutions team will be on hand in the Massachusetts Pavilion. Come talk with us about how we can help you bring your innovations to market as fast and robust as possible.

Merck: Our full portfolio beyond biodevelopment
Tuesday June 5th - Thursday June 7th, Booth #1163

Meet with our team of experts at Booth #1163 and explore our latest products and services for an integrated approach to upstream process development. Let’s explore your path to success at BIO – from developing high producing clones, to characterizing for quality attributes, scaling to from benchtop to process scale, and produce high titers in defined media and supplements.

About BioReliance® End-to-End Solutions

The new BioDevelopment Center is located at the Merck Burlington Campus. It is the latest addition to our process development and clinical manufacturing capabilities.

With experience of 31 years over 230 biologics at our Martillac (France) facility, BioReliance® End-to-End Solutions is bringing our expertise closer to Greater Boston and North America Biotechs.

With a global network of BioDevelopment Centers in Shanghai, Martillac, and Burlington, BioReliance® End-to-End Solutions supports biotechs to accelerate time to clinic in a financially viable way.

• Process Development
• Analytical development
• GMP Clinical Supply
• Facility Design
• Scale up and Tech transfer